Home treatment of deep vein thrombosis: A two-years experience of a single institution

Haematologica

Volumn 83, Issue 5, 1998, Pages 438-441

  Grau, Enric ^a   Real, Esperanza ^a   Pastor, Emilio ^a   Viciano, Vicent ^a   Aguiló, Javier ^a  

^a HOSPITAL LLUÍS ALCANYÍS   (Spain)

Author keywords

Deep vein; Home treatment; Low molecular weight heparin; Thrombosis

Indexed keywords

ACENOCOUMAROL; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FEMALE; HOME CARE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOPHLEBITIS;

EID: 0031837145     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 1991; 151:933-8.
2. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232:155-60.
3. Clark S. Current issues in management of thrombosis. Lancet 1995; 346:113-4.
4. Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996; 335:1816-28.
5. Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972; 287:325-7.
6. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 1: heparin. Circulation 1994; 89:1449-68.
7. Simonneau G, Charbonnier B, Descousus H, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 1993; 153:1541-6.
8. Prandoni P, Lensing AWA, Büller HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992; 339:441-51.
9. Hull RD, Raskob GE, Pineo GF, et al. Sucbutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326:975-82.
10. Lindmarker P, Holmström M, Granqvist S, Johnsson H, Lockner D. Comparison of once-daily subcutaneous fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1994; 72:186-90.
11. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy of low-molecular weight heparins and unfractionated heparin in initial treatment of deep vein thrombosis: a meta-analysis. Br Med J 1994; 309:299-304.
12. Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep vein thrombosis with low molecular heparins. A meta-analysis. Arch Intern Med 1995; 155:601-7.
13. Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg JS. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996; 100:269-77.
14. Grau E. Prevention and treatment of venous thromboembolism: fragmin vs unfractionated heparin. Lab Medica Int 1995; September-October:20-3.
15. Harenberg J, Heene DL. Pharmacology and special clinical applications of low-molecular-weight heparin. Am J Hematol 1988; 29:233-40.
16. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334:677-81.
17. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334:682-7.
18. Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82:423-8.
19. Schafer AI. Low-molecular-weight heparin-an opportunity for home treatment of venous thrombosis. N Engl J Med 1996; 334:724-5.
20. Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with DVT. N Engl J Med 1990; 323:1512-6.
21. Grau E, Linares M, Estany A, Martin F. Utility of D-dimer in the diagnosis of deep vein thrombosis in outpatients. Thromb Haemost 1991; 66:510.
22. Strandness DE, Langlois Y, Cramer M, Randlett A, Thiele BL Long-term sequelae of acute venous thrombosis. Jama 1983; 250:1289-92.
23. Immelman EJ, Jeffery PC. The postphlebitic syndrome. Pathophysiology, prevention and management. Clin Chest Med 1984; 5:537-50.